149 related articles for article (PubMed ID: 15270282)
1. [Perineal radical prostatectomy as monotherapy: ten-year experience].
Martínez de la Riva SI; López-Tomasety JB; Marrero Domínguez R; Santamaría Blanco P
Arch Esp Urol; 2004 May; 57(4):397-411. PubMed ID: 15270282
[TBL] [Abstract][Full Text] [Related]
2. [Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up].
Isorna Martínez de la Riva S; Belón López-Tomasety J; Marrero Domínguez R; Alvarez Cruz E; Santamaría Blanco P
Arch Esp Urol; 2004 Sep; 57(7):679-92. PubMed ID: 15536949
[TBL] [Abstract][Full Text] [Related]
3. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
[TBL] [Abstract][Full Text] [Related]
4. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
5. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
6. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
[TBL] [Abstract][Full Text] [Related]
7. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
Carini M; Masieri L; Minervini A; Lapini A; Serni S
Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
[TBL] [Abstract][Full Text] [Related]
8. Perineal salvage prostatectomy for radiation resistant prostate cancer.
van der Poel HG; Beetsma DB; van Boven H; Horenblas S
Eur Urol; 2007 Jun; 51(6):1565-71; discussion 1572. PubMed ID: 16949728
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
10. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
Gonzalez CM; Roehl KA; Antenor JV; Blunt LW; Han M; Catalona WJ
Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709
[TBL] [Abstract][Full Text] [Related]
11. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
12. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW
Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy: a single surgeon comparison of retropubic, perineal, and robotic approaches.
Boris RS; Kaul SA; Sarle RC; Stricker HJ
Can J Urol; 2007 Jun; 14(3):3566-70. PubMed ID: 17594747
[TBL] [Abstract][Full Text] [Related]
15. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y
Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic radical prostatectomy: a critical analysis of surgical quality.
Touijer K; Guillonneau B
Eur Urol; 2006 Apr; 49(4):625-32. PubMed ID: 16488072
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary results in a series of patients with prostate cancer who underwent radical prostatectomy].
Chiva Robles V; Luján Galán M; Páez Borda A; Santos Arrontes D; Espinales Castro G; Berenguer Sánchez A
Arch Esp Urol; 2004 Mar; 57(2):111-8. PubMed ID: 15074779
[TBL] [Abstract][Full Text] [Related]
19. Oncologic outcome and continence recovery after laparoscopic radical prostatectomy: 3 years' follow-up in a "second generation center".
Galli S; Simonato A; Bozzola A; Gregori A; Lissiani A; Scaburri A; Gaboardi F
Eur Urol; 2006 May; 49(5):859-65. PubMed ID: 16519991
[TBL] [Abstract][Full Text] [Related]
20. [Radical perineal prostatectomy--surgical technique, first results].
Mshvildadze ShT; Udzhmadzhuridze AN; Managadze GL; Shtakl' V
Georgian Med News; 2007 Feb; (143):58-63. PubMed ID: 17404442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]